Zdrowie i gospodarka · 22/07/2002

FDA Submits Information Collection for OMB Review

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its efforts to improve postmarketing adverse drug experience reporting.